Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

80%

4 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
4(100.0%)
4Total
Phase 4(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01109511Phase 4Completed

A Comparison of Oxycodone/Naloxone and Oxycodone After Laparoscopic Hysterectomy

Role: collaborator

NCT01812733Completed

Non-interventional Study Comparing Targiniq and Oxycodone/Laxatives

Role: lead

NCT01276431Phase 4Completed

Norspan Efficacy and Safety Among Elderly Subjects

Role: lead

NCT01449123Phase 4Completed

Mannitol Challenge Test in Adult Asthma Patients With Fixed Dose Combinations

Role: lead

NCT00399178Phase 4Completed

A Randomised Open Controlled Parallel Group Study Comparing Norspan and Tramadol

Role: lead

All 5 trials loaded